Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation

Transplantation

Volumn 73, Issue 3, 2002, Pages 469-472

  Do, Khoa D ^a   Banner, Barbara F ^a   Katz, Eliezer ^a   Szymanski, Irma O ^a   Bonkovsky, Herbert L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FERROCHELATASE; HEME;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; DRUG EFFECT; ENZYME METABOLISM; ERYTHROCYTE; ERYTHROPOIETIC PROTOPORPHYRIA; HEME SYNTHESIS; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEM CELL;

EID: 0037083764     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202150-00024     Document Type: Article

References (10)

1. The porphyrias
2. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria
3. Intravenous hemealbumin in acute intermittent porphyria: Evidence for repletion of hepatic hemoproteins and regulatory heme pools
4. Long-term follow-up after liver transplantation for erythropoietic protoporphyria
5. Follow-up after liver transplantation for protoporphyric liver disease
6. Repression of hepatic delta-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase
7. Advances in understanding and treating 'the little imitator,' acute porphyria
8. Hematin therapy in children with protoporphyric liver disease
9. Differential effects of metalloporphyrins on mRNA levels of delta-aminolevulinate synthase and heme-oxygenase: Studies in cultured chick embryo liver cells
10. Reversion of hepatobiliary alterations by bone marrow transplantation in a murine model of erythropoietic protoporphria